Cardiovascular burden of TTR gene variant among Black carriers across mid to late-life

FHS
May 15, 2024
11:56 am

The key contribution of this study was to provide more accurate estimates of cardiovascular risk across mid to late life, compared to previously existing analyses.

Hawthorne Gardening Q4 Revenue Slips 3% Sequentially

ScottsMiracle-Gro Announces Fiscal 2023 Full-Year Results Full-year total Company net sales of $3.55 billion in line with guidance Free cash flow of $438 million improved

November 1, 2023

FDA again rejects AbbVie’s continuous infusion therapy for Parkinson’s

The FDA has rejected a new Parkinson’s drug from AbbVie for a second time. Regulators turned away ABBV-951, a 24-hour infusion therapy to treat advanced

June 26, 2024

Nucleai Secures $14M to Enhance Clinical Trial Enrollment with Spatial AI Biomarker

What You Should Know: – Nucleai, a pioneer in spatial AI biomarkers raises $14M in funding led by M Ventures, the corporate venture arm of

April 4, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.